Late-onset neutropenia following rituximab treatment in patients with autoimmune diseases
- 1 December 2007
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 157 (6), 1271-1273
- https://doi.org/10.1111/j.1365-2133.2007.08189.x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patientsBritish Journal of Dermatology, 2007
- Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)Blood, 2006
- Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trialBlood, 2006
- A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution studyAnnals of Oncology, 2006
- Rituximab‐induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemiaBritish Journal of Haematology, 2006
- Delayed-onset peripheral blood cytopenia after rituximab: Frequency and risk factor assessment in a consecutive series of 77 treatmentsLeukemia & Lymphoma, 2006
- Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesAnnals Of The Rheumatic Diseases, 2005
- Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphomaBone Marrow Transplantation, 2004
- Delayed‐onset neutropenia associated with rituximab therapyBritish Journal of Haematology, 2003
- Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpuraBlood, 2001